文献速递关节外科

骨内注射吗啡在全膝关节置换术后疼痛控制中的效果:双盲随机试验

Effectiveness of Intraosseous Morphine for Pain Control in Total Knee Arthroplasty: A Double-Blinded, Randomized Trial.
PubMed 文献 · J Bone Joint Surg Am · 2026-04-21

该双盲随机对照试验纳入100例择期初次全膝关节置换术患者,比较骨内注射含10 mg吗啡与500 mg万古霉素的生理盐水溶液与不含吗啡的相同注射液的镇痛效果。结果显示,两组在术后14天内每日疼痛评分和吗啡毫克当量消耗均无显著差异,骨内注射吗啡未能改善疼痛控制或减少麻醉药品消耗。

要点

  • 骨内注射吗啡未显著改善全膝关节置换术后14天内的每日疼痛评分。
  • 骨内注射吗啡未显著减少术后每日及每周吗啡毫克当量消耗。
  • 该研究为双盲随机对照试验,证据等级为治疗性I级。

核心结论

  • 在择期初次全膝关节置换术患者中,骨内注射吗啡未显著改善术后14天内的疼痛控制或减少麻醉药品消耗。

研究设计与样本

  • 双盲随机对照试验,前瞻性纳入100例择期初次全膝关节置换术患者,最终88例纳入分析。
  • 所有患者接受脊髓麻醉和静脉镇静,并联合术中由外科医生实施的收肌管阻滞。
  • 实验组接受含10 mg吗啡和500 mg万古霉素的110 mL生理盐水溶液骨内注射,对照组接受相同但不含吗啡的注射液。
  • 术后14天每天通过6次短信调查(上午3次、下午3次)收集疼痛评分、吗啡毫克当量消耗及恶心呕吐事件。
  • 采用线性混合效应模型进行分析。

主要发现

  • 线性混合效应模型显示,两组在术后14天内任何时间点的每日疼痛评分均无差异(p = 0.969)。
  • 两组在术后14天内任何时间点的每日吗啡毫克当量消耗均无差异(p = 0.377)。
  • 两组术后总吗啡毫克当量消耗或每周吗啡毫克当量消耗均无差异(p ≥ 0.878)。
  • 纳入分析的88例患者中,52.3%(n = 46)为女性,平均年龄69.1 ± 9.0岁(范围46至89岁),89.8%(n = 79)为白人。

临床怎么用

  • 基于本试验结果,不推荐在择期初次全膝关节置换术中常规添加骨内注射吗啡以改善术后疼痛控制或减少麻醉药品消耗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Effective pain management following total knee arthroplasty (TKA) is crucial to optimizing patient outcomes and experiences. Multimodal pain management protocols vary between institutions, with some recently proposing the addition of an intraosseous (IO) injection of morphine intraoperatively. The purpose of this study was to investigate whether the addition of an intraoperative, IO injection of morphine during elective primary TKA would lead to improved pain control and decreased narcotic consumption during the postoperative period. METHODS: In this double-blinded, randomized controlled trial, 100 patients undergoing elective primary TKA were prospectively enrolled. All patients received spinal anesthesia and intravenous sedation combined with an intraoperative, surgeon-administered adductor canal block. The experimental group received an intraoperative, IO injection containing 10 mg of morphine and 500 mg of vancomycin in 110 mL of normal saline solution. The control group received the same injection but without morphine. All patients received 6 daily text-message surveys (3 in the morning and 3 in the evening) for 14 days postoperatively to collect pain scores, morphine milligram equivalent (MME) consumption, and nausea and vomiting events. Data on demographics, operative factors, post-anesthesia care unit (PACU) pain scores, PACU MME consumption, and patient-reported outcomes were also collected. Linear mixed-effects (LME) models were utilized. RESULTS: A total of 88 patients (52.3% [n = 46] female; mean age, 69.1 ± 9.0 years [range, 46 to 89 years]; 89.8% [n = 79] White) were included in the analysis. The LME model demonstrated no differences between the groups with respect to daily pain scores at any time point within 14 days postoperatively (p = 0.969). There were no differences between the groups with respect to daily MME consumption at any time point within 14 days postoperatively (p = 0.377). There were also no differences in total MME consumption or weekly MME consumption postoperatively (p ≥ 0.878). CONCLUSIONS: IO morphine did not significantly improve postoperative pain control or decrease narcotic consumption up to 2 weeks postoperatively among patients undergoing elective primary TKA. LEVEL OF EVIDENCE: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Pekas DR, Adrados M, Lee MM, et al. Effectiveness of Intraosseous Morphine for Pain Control in Total Knee Arthroplasty: A Double-Blinded, Randomized Trial. J Bone Joint Surg Am. 2026. PMID: 42013190. doi:10.2106/JBJS.25.01037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。